Posted inBiotechnology
Factors Shaping Rice Farmers’ Climate Adaptation in Bogura
In the face of increasing climate change impacts, particularly in developing nations, understanding how agricultural communities adapt to these challenges…
Posted inBiotechnology
Blastocystis Boosts B and K2 Vitamins in Antelope Gut
Recent research has unveiled fascinating insights into the interplay between gut microbiota and host health, particularly in the vulnerable Tibetan…
Posted inBiotechnology
Activated Carbon from Spinach Waste for Supercapacitors
Researchers from various disciplines have recently converged on a fascinating exploration of sustainable materials for energy storage. The need for…
Posted inBiotechnology
Higher Body Weight Linked to Stigmatizing Birth Notes
In a groundbreaking study poised to reshape the landscape of maternal healthcare, researchers have unveiled unsettling evidence of pervasive weight…
Posted inBiotechnology
New Intermediate Host Found for Fish Parasite
In a compelling advancement within the realm of parasitology and aquatic biology, recent research from the Philippines has unveiled a…
Posted inBiotechnology
Breakthrough Mo-CoNiFe-S/NF Catalyst Dramatically Enhances Oxygen Evolution
In a groundbreaking development in the field of catalysis, researchers have unveiled a novel electrocatalyst composed of molybdenum, cobalt, nickel,…
Posted inBiotechnology
Compulsive Internet Use Linked to Vamping, FOMO, Procrastination
In an era dominated by digital connectivity, the way individuals engage with the internet has increasingly become a focal point…
Posted inGenetics
Charles River Laboratories Acquires PathoQuest and K.F. (Cambodia)
Charles River Laboratories (CRL) exercised its option to acquire the remaining 79% equity stake that it does not already own…
Posted inBiotechnology
Hidden Parasites in Saudi Rodents: Molecular Insights
In a groundbreaking study that could reshape our understanding of zoonotic diseases and their vectors, researchers have shed light on…
Posted inBiotechnology
JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a ‘position of strength’
Still riding the high of last year’s twice-yearly HIV PrEP approval of lenacapavir as Yeztugo, Gilead Sciences is approaching deal-making…